Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Boeck (Cambridge, United Kingdom), M. Skwark (Cambridge, United Kingdom), W. Pearson (London, United Kingdom), S. Burbaud (Cambridge, United Kingdom), J. Sangen (Cambridge, United Kingdom), S. Malhotra (Cambridge, United Kingdom), J. Bryant (Cambridge, United Kingdom), T. Blundell (Cambridge, United Kingdom), M. Dionne (London, United Kingdom), J. Parkhill (Cambridge, United Kingdom), A. Floto (Cambridge, United Kingdom). Late Breaking Abstract - Multidimensional genomic mapping reveals the pathophysiology of Mycobacterium abscessus. 5450

Member's Comments

No comment yet.

Related content which might interest you: Characterization of extensively drug-resistant mycobacterium tuberculosis in Siberia Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Can M. smegmatis be used as a real alternative for M. tuberculosis? Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021 Year: 2022 Pulmonary Mycobacterium abscessus: can we identify the road to improved outcomes? Source: Eur Respir J, 54 (1) 1901121; 10.1183/13993003.01121-2019 Year: 2019 Late Breaking Abstract - Clinical and epidemiological characteristics of Co-infection: respiratory tuberculosis and COVID-19. Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 Whole genome-sequencing of non-tuberculous mycobacteria Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Lung function evolution in patients with microbiological isolation of Mycobacterium abscessus Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Treatment of human disease due to Mycobacterium bovis: a systematic review Source: Eur Respir J 2016; 48: 1500-1503 Year: 2016 Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Late Breaking Abstract - Spatial distribution and environmental risk factors of nontuberculous mycobacterial pulmonary disease in Japan Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis Year: 2017 Development of a prognostic scoring system for Mycobacterium avium complex lung disease Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Species-specific Interferon-Gamma Release Assay for the diagnosis of Mycobacterium abscessus complex infection in Cystic Fibrosis patients. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 Quantitative membrane proteomics reveals new functions ofCD13 in mycobacterium tuberculosis infection Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015 Genetic diversity of multidrug resistant mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran, using MIRU-VNTR technique Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Late Breaking Abstract - Use of non-tuberculous mycobacteria (NTM) specific antigens to detect NTM infection Source: International Congress 2019 – The microbiome: novel data across respiratory diseases Year: 2019 Characteristics of patients with isolation of mycobacterium xenopi Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Clinical analysis of pulmonary Mycobacterium kansasii disease Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Study of genetic heterogeneity in Mycobacterium tuberculosis isolates from tuberculosis patients using DNA fingerprinting Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005 Late Breaking Abstract - Transcriptomic signature for precise prediction of systemic drug reaction during 3HP treatment for latent tuberculosis infection Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 Standardised PCR-based molecular epidemiology of tuberculosis Source: Eur Respir J 2008; 31: 1077-1084 Year: 2008